Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIVV | SRPT | QGEN | ||
| Company | Bioverativ Inc | Sarepta Therapeutics | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 104.97 | 132.88 | 45.81 | ||
| High | 105.01 | 133.12 | 45.92 | ||
| Low | 104.97 | 129.50 | 45.62 | ||
| Last | 104.98 | 131.38 | 45.69 | ||
| Change | +0.33 | -1.36 | -0.30 | ||
| % Change | +0.32% | -1.02% | -0.65% | ||
| Volume | 792,900 | 848,474 | 1,274,938 | ||
| 20-Day Average Volume | 2,587,600 | 1,176,794 | 1,288,935 | ||
| Previous Close | 104.65 | 132.74 | 45.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 104.18 | 129.70 | 43.16 | ||
| 20-Day Raw Stochastic | 98.80% | 52.48% | 94.13% | ||
| 20-Day Relative Strength | 86.97% | 56.15% | 67.10% | ||
| Weighted Alpha | +58.00 | +10.54 | +5.63 | ||
| Today's Opinion | N/A | 100% Buy | 72% Buy | ||
| Previous Opinion | N/A | 100% Buy | 72% Buy | ||
| Last Month's Opinion | N/A | 40% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/01/18 | -0.33% since 05/10/24 | +4.77% since 05/10/24 | ||
| Low | 104.14 on 03/06/18 | 129.50 on 05/17/24 | 43.82 on 05/13/24 | ||
| High | 105.01 on 03/08/18 | 134.71 on 05/15/24 | 46.01 on 05/16/24 | ||
| 1-Month | |||||
| %Chg | +1.78% since 02/08/18 | +11.44% since 04/17/24 | +16.47% since 04/17/24 | ||
| Low | 102.51 on 02/09/18 | 114.37 on 04/19/24 | 39.03 on 04/18/24 | ||
| High | 105.01 on 03/08/18 | 146.68 on 05/07/24 | 46.01 on 05/16/24 | ||
| 3-Month | |||||
| %Chg | +103.96% since 12/08/17 | -2.40% since 02/16/24 | +6.11% since 02/16/24 | ||
| Low | 51.25 on 12/11/17 | 114.37 on 04/19/24 | 39.03 on 04/18/24 | ||
| High | 105.01 on 03/08/18 | 146.68 on 05/07/24 | 46.01 on 05/16/24 | ||
| 6-Month | |||||
| %Chg | +83.92% since 09/08/17 | +58.00% since 11/17/23 | +16.11% since 11/17/23 | ||
| Low | 48.28 on 12/01/17 | 78.67 on 12/01/23 | 39.03 on 04/18/24 | ||
| High | 105.01 on 03/08/18 | 146.68 on 05/07/24 | 46.01 on 05/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,360,936 | 12,547,116 | 10,495,056 | ||
| Shares Outstanding, K | 108,220 | 94,524 | 228,203 | ||
| Annual Sales | 1,168,500,000 | 1,243,340,000 | 1,965,310,000 | ||
| Annual Net Income | 355,600,000 | -535,980,000 | 341,300,000 | ||
| Last Quarter Sales | 328,700,000 | 413,460,000 | 458,800,000 | ||
| Last Quarter Net Income | 96,300,000 | 36,120,000 | 80,670,000 | ||
| 60-Month Beta | N/A | 0.95 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.95 on 02/13/18 | 0.73 on 05/01/24 | 0.46 on 04/29/24 | ||
| Latest Earnings Date | 05/02/18 | 05/01/24 | 04/29/24 | ||
| Most Recent Dividend | N/A | N/A | 0.027 on 12/27/02 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.05 | 1,104.17 | 22.31 | ||